(Q41981996)

English

Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression

scientific article published on 10 November 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression (English)

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Joseph R Calabrese

16

object named as

Joseph R Calabrese

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

2

object named as

Stephen J Ganocy

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

author name string

David E Kemp

1

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Martin Brecher

3

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Berit X Carlson

4

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Suzanne Edwards

5

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

James M Eudicone

6

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Gary Evoniuk

7

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Wim Jansen

8

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Andrew C Leon

9

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Margaret Minkwitz

10

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Andrei Pikalov

11

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Hans H Stassen

12

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Armin Szegedi

13

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Mauricio Tohen

14

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Arjen P P Van Willigenburg

15

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

publication date

10 November 2010

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Journal of Affective Disorders

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

130

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

1-2

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

171-179

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Predictive value of early improvement in bipolar depression trials: a post-hoc pooled analysis of two 8-week aripiprazole studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

5 June 2018

Does early improvement in major depression protect against treatment emergent suicidal ideation?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

5 June 2018

Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

5 June 2018

Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

5 June 2018

Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

5 June 2018

Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

5 June 2018

Differentiating Bipolar Disorders from Major Depressive Disorders: Treatment Implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

5 June 2018

Effectiveness of adjunctive antidepressant treatment for bipolar depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

5 June 2018

Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

5 June 2018

Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

5 June 2018

Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

5 June 2018

Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

5 June 2018

Psychosocial Disability in the Course of Bipolar I and II Disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

5 June 2018

The dark side of bipolarity: detecting bipolar depression in its pleomorphic expressions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

5 June 2018

A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

5 June 2018

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

5 June 2018

Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

5 June 2018

Determinants of functional outcome and healthcare costs in bipolar disorder: a high-intensity follow-up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

5 June 2018

How fast are antidepressants?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

5 June 2018

Fluoxetine versus moclobemide: cross-comparison between the time courses of improvement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

5 June 2018

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

5 June 2018

Onset of antidepressant activity: reexamining the structure of depression and multiple actions of drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

5 June 2018

Use of pattern analysis to identify true drug response. A replication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

5 June 2018

The Measurement of Observer Agreement for Categorical Data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

5 June 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

5 June 2018

Rapid antipsychotic response with ziprasidone predicts subsequent acute manic/mixed episode remission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

18 August 2018

Optimal thresholds of early response to atypical antipsychotics: application of signal detection methods

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

18 August 2018

Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

18 August 2018

Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

18 August 2018

Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

18 August 2018

Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

18 August 2018

Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

18 August 2018

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

18 August 2018

Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

18 August 2018

The long-term natural history of the weekly symptomatic status of bipolar I disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073691

18 August 2018

Identification of true drug response to antidepressants. Use of pattern analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21071096

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time course of improvement under antidepressant treatment: a survival-analytical approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/21071096

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early nonresponse to fluoxetine as a predictor of poor 8-week outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/21071096

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Delayed onset of action of antidepressant drugs? Survey of results of Zurich meta-analyses

1 reference

https://pubmed.ncbi.nlm.nih.gov/21071096

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can the effects of antidepressants be observed in the first two weeks of treatment?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21071096

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of depressive symptoms compared with manic symptoms in bipolar disorder: results of a U.S. community-based sample

1 reference

https://pubmed.ncbi.nlm.nih.gov/21071096

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is there a delay in the antidepressant effect? A meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21071096

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.JAD.2010.10.026

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41981996&oldid=1954137538"